Memorial Sloan Kettering Cancer Center: all 1,959 studies

Page 19 of 20. Open to participants first (325), then studies with results posted, then the rest; newest registration first within each.

• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00008294Phase 1
• Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple MyelomaCompletedNCT00008268Phase 2
• INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung CancerCompletedNCT00008255Phase 2
• Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple MyelomaCompletedNCT00008242Phase 2
• Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00006485Phase 1
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00006381Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Prostate CancerCompletedNCT00006380Phase 1
• Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00006377Phase 2
• LY293111 in Treating Patients With Advanced Solid TumorsCompletedNCT00006375Phase 1
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckCompletedNCT00006361Phase 2
• Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous PaclitaxelCompletedNCT00006245Phase 2
• PS-341 in Treating Patients With Hematologic CancerCompletedNCT00006098Phase 1
• Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone TherapyCompletedNCT00006044Phase 1
• Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to CisplatinCompletedNCT00006043Phase 2
• Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00006041Phase 1
• Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory LeukemiaCompletedNCT00006040Phase 1
• Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaCompletedNCT00006039Phase 2
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
• Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT00006019Phase 2
• Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNCT00005999Phase 2
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
• Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00005814Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00005806Phase 1
• St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00005791Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00005638Phase 1
• Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaCompletedNCT00005637Phase 1
• Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by SurgeryCompletedNCT00005636Phase 3
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00005634Phase 1
• Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005633Phase 1
• Vaccine Therapy Plus QS21 in Treating Patients With Prostate CancerCompletedNCT00005632Phase 1
• Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaCompletedNCT00005631Phase 2
• Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerCompletedNCT00005630Phase 1
• Vaccine Therapy in Treating Patients With Recurrent Soft Tissue SarcomaCompletedNCT00005628Phase 2
• Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic OsteosarcomaCompletedNCT00005625Phase 2
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous LeukemiaCompletedNCT00005618Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Colorectal CancerCompletedNCT00005616Phase 1
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
• Irofulven in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNCT00005070Phase 2
• Arsenic Trioxide in Treating Patients With Metastatic Kidney CancerCompletedNCT00005069Phase 2
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
• Trastuzumab in Treating Patients With Recurrent OsteosarcomaCompletedNCT00005033Phase 2
• Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesCompletedNCT00004930Phase 1
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerCompletedNCT00004929Phase 1
• Calcitriol and Zoledronate in Treating Patients With Progressive Prostate CancerCompletedNCT00004928Phase 1
• ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004926Phase 1
• Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast CancerCompletedNCT00004925Phase 1/2
• Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsCompletedNCT00004922Phase 2
• PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During SurgeryCompletedNCT00004891Not applicable
• BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNCT00004877Phase 1
• Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By SurgeryCompletedNCT00004250Phase 2
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial TherapyCompletedNCT00004249Phase 2
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaCompletedNCT00004245Phase 1
• 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00004238Phase 2
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00004215Phase 2
• Vaccine Therapy in Treating Patients With Breast CancerCompletedNCT00004156Phase 1
• PET and CT Scans to Evaluate Patients With Stage III or Stage IV MelanomaCompletedNCT00004152Phase 2
• Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
• Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With NeuroblastomaCompletedNCT00004110Phase 2
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerCompletedNCT00004061Phase 2
• Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid TumorsCompletedNCT00004059Phase 1
• Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
• Vaccine Therapy in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00004052Phase 2
• Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00004051Phase 1
• Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00004042Phase 1
• Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00004012Phase 2
• Vaccine Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003959Phase 1
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003956Phase 1
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedNCT00003923Phase 2
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerCompletedNCT00003819Phase 1
• Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic OsteosarcomaCompletedNCT00003776Phase 2
• Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid TumorCompletedNCT00003755Phase 1
• Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood CancersCompletedNCT00003754Phase 2
• Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003753Phase 2
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00003742Phase 1
• Trastuzumab in Treating Patients With Prostate CancerCompletedNCT00003740Phase 2
• Rebeccamycin Analog in Treating Children With Relapsed or Refractory NeuroblastomaCompletedNCT00003737Phase 2
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersCompletedNCT00003658Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System LymphomaCompletedNCT00003632Phase 2
• Arsenic Trioxide in Treating Patients With Advanced Solid TumorsCompletedNCT00003630Phase 1
• Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003544Phase 2
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00003543Phase 1
• Interferon Alfa in Treating Patients With Advanced Kidney CancerCompletedNCT00003542Phase 1/2
• Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell LymphomaCompletedNCT00003541Phase 1/2
• Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and PaclitaxelCompletedNCT00003540Phase 2
• Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00003539Phase 2
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003443Phase 2
• L-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003430Phase 1
• PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing SurgeryCompletedNCT00003429Not applicable
• Hormone Therapy in Treating Women With Breast CancerCompletedNCT00003428Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003426Phase 1
• Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Prostate CancerCompletedNCT00003394Phase 1/2
• 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerCompletedNCT00003390Phase 2
• Diet and PSA Levels in Patients With Prostate CancerCompletedNCT00003367Phase 3

← Memorial Sloan Kettering Cancer Center overview and focus areas